`
`Oct 31, 2017
`
`Docket/Reference
`Number:
`
`Novartis Pharma AG,
`Trademark Department
`Postfach
`CH-4002 Basel
`SWITZERLAND
`
`1. YOUR APPLICATION RECEIVED: We have received your U.S. Trademark Application and assigned the serial number listed below to your submission. A summary of
`your application data is provided at the bottom and serves as your official filing receipt. Please keep a copy of this information for your records. All correspondence concerning
`the application should reference your assigned serial number.
`
`Please read all of the important information below. Not every mark is registrable with the USPTO and we do not refund the application filing fee(s) if a registration does not
`ultimately issue.
`
`2. RECEIVING E-MAIL COMMUNICATIONS/FILING DOCUMENTS ON-LINE: If you authorize receipt of correspondence by e-mail, please make sure that your server will
`accept USPTO e-mail and not treat it as SPAM. If you have not authorized communication by e-mail, please do so at any time by using the "Change of Correspondence
`Address" form, available at http://teas.uspto.gov/ccr/cca. If you must submit correspondence to us, please use the Trademark Electronic Application System (TEAS) forms,
`available at http://www.uspto.gov/trademarks/teas/index.jsp.
`
`3. KEEP YOUR ADDRESS CURRENT IN USPTO RECORDS: We do not extend filing deadlines due to a failure to receive USPTO mailings/e-mailings. You must update the
`correspondence and/or owner's address if a postal address and/or e-mail address changes, using the form(s) available at http://www.uspto.gov/teas/eTEASpageE.htm.
`
`4. WARNING ABOUT UNSOLICITED COMMUNICATIONS: You may receive trademark-related communications from private companies not associated with the
`USPTO. These communications frequently display customer-specific information, including your USPTO serial number or registration number and owner name, and
`request fees for trademark-related services, such as monitoring, listings in international publications, and document filing. None of the companies offering these services are
`affiliated with the USPTO or any other federal agency. All official correspondence will be from the "United States Patent and Trademark Office" in Alexandria, VA, and if by e-
`mail, specifically from the domain "@uspto.gov." Please consult the "Warning" page on the Trademarks section of the USPTO's website for further information about unsolicited
`communications and to view representative examples of them. For general information on filing and maintenance requirements for trademark applications and registrations,
`including fees required by law, please consult www.uspto.gov, contact the TrademarkAssistanceCenter@uspto.gov or telephone 1-800-786-9199.
`
`5. LEGAL EXAMINATION PROCESS: Your application is now pending examination. In approximately 3 months, your application will be assigned to a USPTO examining
`attorney for review. The application cannot mature into a registration unless all legal requirements are met, and many applications never satisfy these requirements and
`therefore never register. The overall process can take up to 18 months.
`
`6. CHECK STATUS AND REVIEW DOCUMENTS OR YOUR APPLICATION MAY BE UNINTENTIONALLY ABANDONED: You must check the status and review all
`documents associated with your application at least every 3-4 months using Trademark Status and Document Retrieval (TSDR), available at http://tsdr.uspto.gov/.
`
`Promptly e-mail the TrademarkAssistanceCenter@uspto.gov or telephone 1-800-786-9199 (select option #1) if an Office action (letter from the USPTO) or notice has issued for
`your application that you did not receive or do not understand. Failure to respond timely to any Office action or notice may result in the abandonment of your application,
`requiring you to pay an additional fee to have your application revived even if you did not receive the Office action or notice.
`
`7. FILING ERRORS: If you discover an error in the application data, you must file a Voluntary Amendment at http://www.uspto.gov/trademarks/teas/miscellaneous.jsp. Please
`wait approximately 7 days after the filing date of your application to submit a Voluntary Amendment in order to allow for initial upload of your application data into the USPTO
`database. The assigned examining attorney will determine the acceptability of any Voluntary Amendment during examination. Not all errors may be corrected. For example, if
`you submitted the wrong mark or if the proposed correction would be considered a material alteration to your original filing, it will not be accepted. In this situation, your only
`recourse would be to file a new application, with a new fee and no refund of your original filing fee.
`
`8. REQUEST FOR REFUND AND/OR CANCELLATION: Since your application has already been assigned a serial number, please do not request a refund or to cancel the
`filing. We will only cancel the filing and refund the filing fee if the application does not meet minimum filing requirements. The fee is a processing fee that the USPTO does not
`refund, even if your mark does not proceed to registration.
`
`9. SelectUSA: The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location for business investment, innovation, and
`commercialization of new technologies. The U.S. offers tremendous resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our
`nation works to promote and facilitate business investment. SelectUSA provides information assistance to the international investor community; serves as an ombudsman for
`existing and potential investors; advocates on behalf of U.S. cities, states, and regions competing for global investment; and counsels U.S. economic development
`organizations on investment attraction best practices. To learn more about why the United States is the best country in the world to develop technology, manufacture products,
`deliver services, and grow your business, visit SelectUSA.gov or call +1-202-482-6800.
`
`PLEASE REVIEW THE ACCURACY OF THE FILING RECEIPT DATA.
`A request for correction to the filing receipt should be submitted within 30 days. Such requests may be submitted by mail to: COMMISSIONER FOR TRADEMARKS, P.O. BOX 1451,
`ALEXANDRIA, VIRGINIA 22313-1451; by fax to 571-273-9913; or by e-mail to tmfiling.receipt@uspto.gov. The USPTO will review the request and make corrections when appropriate.
`
`SERIAL NUMBER:
`FILING DATE:
`REGISTER:
`MARK:
`MARK TYPE(S):
`DRAWING TYPE:
`FILING BASIS:
`
`79219215
`Aug 23, 2017
`Principal
`PIKEVOR
`Trademark
`Standard Character Mark
`Sect. 66(a)(Madrid Protocol)
`
`OWNER:
`
`Novartis AG (SWITZERLAND, Aktiengesellschaft (AG))
`CH-4002 Basel
`, SWITZERLAND
`
`
`
`FOR:
`
`Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological
`pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical
`preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases;
`pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the
`musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical
`preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm
`disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the
`prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the
`prevention and treatment of hypertension, pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in
`dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention
`and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention
`and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
`INT. CLASS: 005
`FIRST USE: NONE USE IN COMMERCE: NONE
`
`INTERNATIONAL REG. NUMBER: 1211748
`
`ALL OF THE GOODS/SERVICES IN EACH CLASS ARE LISTED
`
`INTERNATIONAL OR FOREIGN REGISTRATION DATA
`
`Note on representation: An attorney who is a member in good standing of the bar of the highest court of any U.S. state may practice before the USPTO in trademark matters.
`See http://tess2.uspto.gov/tmdb/tmep/0600.htm#_T60206 for more information on foreign attorneys and persons who may practice before the Office.
`
`ADDITIONAL INFORMATION MAY BE PRESENT IN THE USPTO RECORDS
`
`

Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ ChargeStill Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.

This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.

One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site